NCT03032367View on ClinicalTrials.gov

TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study)

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 10, 2016

Primary Completion Date

December 9, 2016

Study Completion Date

January 11, 2017

Conditions

Tuberculosis

Interventions

DRUG

bedaquiline

Trial Locations (1)

7530

TASK Clinical Research Centre, Bellville

All Listed Sponsors

collaborator

US National Institute of Allergy and Infectious Diseases

UNKNOWN

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

NETWORK

NCT03032367 - TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study) | Biotech Hunter | Biotech Hunter